Ekso bionics announces 61% increase in first quarter 2023 revenues

Highest quarterly revenues in company history san rafael, calif., april 27, 2023 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company” or “ekso bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended march 31, 2023.
EKSO Ratings Summary
EKSO Quant Ranking